Probiotics can harbor mobile antibiotic resistance genes within the gut microbiome, raising clinical concerns regarding their potential horizontal transfer to other bacterial populations.
The retrieved literature (such as papers [4] and [9]) confirms that commercial and natural probiotics frequently contain antimicrobial resistance genes with mobilization potential, presenting clinical risks via gene exchange in the gut. No papers refute this premise.